CDKN2A and diabetes mellitus: Our data suggest that netrin-1 decreases inflammation through inhibition of NFκB activation, attenuates diabetes-induced COX-2 expression and suppresses apoptotic processes by reducing p16INK4A and caspase-3 activity and expression.